Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for B-lymphoblastic leukemia with NUTM1 rearrangement has been reported in the published literature.
No clinical trials have been registered for B-lymphoblastic leukemia with NUTM1 rearrangement.
3 publications have been identified in PubMed for B-lymphoblastic leukemia with NUTM1 rearrangement. Research spans Diagnostic / Biomarker (67%) and Basic Science / Preclinical (33%).
Nishimura K (2026). [PMID: 41460961](https://pubmed.ncbi.nlm.nih.gov/41460961/). *Blood*. [Basic Science / Preclinical]
Hidalgo-Gómez G (2025). [PMID: 39843811](https://pubmed.ncbi.nlm.nih.gov/39843811/). *Annals of hematology*. [Diagnostic / Biomarker]
Benjamin M (2025). [PMID: 40449797](https://pubmed.ncbi.nlm.nih.gov/40449797/). *Laboratory investigation; a journal of technical methods and pathology*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:38 AM UTC
Common questions about B-lymphoblastic leukemia with NUTM1 rearrangement